USPTO Examiner HOLTZCLAW MICHAEL T - Art Unit 3796

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18915821Sleep diagnostics using cellular and/or internet data transfer from remote testing locationsOctober 2024May 2025Allow720NoNo
18782346PHOTOTHERAPY DEVICEJuly 2024January 2025Allow620YesYes
18679665ADJUSTABLE LEAD SYSTEMS FOR CARDIAC SEPTAL WALL IMPLANTATIONMay 2024November 2025Allow1700YesNo
18638519SYSTEMS AND METHODS FOR ENTERING AND EXITING A TELEOPERATIONAL STATEApril 2024July 2025Allow1520NoNo
18634625ELECTRONIC DEVICE FOR AUSCULTATION AND METHOD OF OPERATION THEREOFApril 2024April 2025Allow1221NoNo
18611865Controllable photonic chamber with customizable environmentMarch 2024February 2026Allow2331NoNo
18593835EXPANDABLE ELEMENTS FOR SHUNTING CATHETERSMarch 2024April 2025Allow1321YesNo
18583399MODULATE PACING RATE TO INCREASE THE PERCENTAGE OF EFFECTIVE VENTRICULAR CAPTURE DURING ATRIAL FIBRILLATIONFebruary 2024August 2025Allow1810YesNo
18422203CONTROLLERS FOR ROBOTICALLY ENABLED TELEOPERATED SYSTEMSJanuary 2024June 2025Allow1720YesNo
18414984Deflectable Mapping Guide Sheath for His Bundle PacingJanuary 2024June 2025Allow1720NoNo
18408727METHOD FOR CONTROLLING FLOW IN A BODILY ORGANJanuary 2024December 2024Allow1110NoNo
18407743DIGITAL KIOSK FOR PERFORMING INTEGRATIVE ANALYSIS OF HEALTH AND DISEASE CONDITION AND METHOD THEREOFJanuary 2024March 2025Allow1421YesNo
18399912Scanning laser ophthalmic treatment system and method of operationDecember 2023July 2025Allow1911NoNo
18541514Sleep diagnostics using cellular and/or internet data transfer from remote testing locationsDecember 2023July 2024Allow720NoNo
18496478TISSUE EXTRACTION DEVICES AND METHODSOctober 2023February 2025Allow1520NoNo
18494591MULTI-SPOT OPHTHALMIC LASEROctober 2023September 2025Abandon2311NoNo
18472497Portable Polysomnography Apparatus And SystemSeptember 2023October 2024Allow1310NoNo
18470904STERILE DRAPING OF ROBOTIC ARMSSeptember 2023April 2025Allow1910NoNo
18467203SYSTEMS AND METHODS FOR USING A ROBOTIC MEDICAL SYSTEMSeptember 2023November 2024Allow1410NoNo
18457700METHOD FOR TREATING ACNE USING LASERAugust 2023December 2025Allow2710YesNo
18450275STEERABLE AND CONTROLLABLE MEDICAL LASER FIBERSAugust 2023September 2025Abandon2620NoNo
18231162SYSTEMS AND METHODS FOR INSPECTION OF ENCAPSULATION AND COMPONENTS IN SENSOR EQUIPPED WOUND DRESSINGSAugust 2023October 2025Allow2610NoNo
18223397INTELLIGENT CORNEAL PROCEDURE ADVISORJuly 2023January 2026Allow3010NoNo
18349790SYSTEMS AND METHODS FOR ALIGNING AN EYE WITH A PATIENT INTERFACE OF AN OPHTHALMIC LASER DEVICEJuly 2023October 2024Allow1620YesNo
18338858THERAPY, TREATMENT, AND PROCESS FOR PHOTODYNAMIC INACTIVATION OF COVID-19June 2023October 2025Allow2810YesNo
18255171METHOD, DEVICE AND SYSTEM FOR REHABILITATING COGNITIVE FUNCTION BY USING VIRTUAL OBJECT MODELMay 2023November 2025Allow2910NoNo
18198327Sleep diagnostics using cellular data transfer from remote testing locationsMay 2023September 2023Allow420NoNo
18315195METHOD FOR PROVIDING CONTROL DATA FOR A LASER OF A TREATMENT APPARATUSMay 2023January 2026Abandon3210NoNo
18143543TEMPERATURE MEASUREMENT FOR OPTICAL FIBER BASED LASER TREATMENTSMay 2023October 2025Allow3010NoNo
18251595INDIVIDUAL OPTIMAL MODE OF DELIVERYMay 2023October 2025Allow2910YesNo
18142944IMPLANTABLE DEVICE HEADER AND METHODMay 2023May 2024Allow1210NoNo
18302715MINIMALLY INVASIVE SURGICAL SYSTEMApril 2023January 2025Allow2110NoNo
18302698MINIMALLY INVASIVE SURGICAL SYSTEMApril 2023January 2024Allow901NoNo
18301130DOCKING AN EYE FOR OPHTHALMIC LASER TREATMENTApril 2023November 2025Allow3111YesNo
18248540METHOD FOR CENTERING A CONTACT GLASS AND REFRACTIVE SURGICAL LASER SYSTEMApril 2023December 2025Allow3210NoNo
18297612Photobiomodulation Therapy Garment, Methods and UsesApril 2023September 2023Allow620NoNo
18124874INTELLIGENT TOPOGRAPHIC CORNEAL PROCEDURE ADVISORMarch 2023September 2025Allow3010YesNo
18123722GRAPHICAL USER GUIDANCE FOR A ROBOTIC SURGICAL SYSTEMMarch 2023March 2025Allow2410YesNo
18025923Avoiding Blood Vessels During Direct Selective Laser TrabeculoplastyMarch 2023November 2025Allow3201NoNo
18182573SURGICAL IMPLANT DELIVERY WITH DUAL MODE DRIVEMarch 2023July 2025Allow2800NoNo
18168923TREATMENT APPARATUS FOR AN EYE TREATMENT, METHOD, COMPUTER PROGRAM AND COMPUTER-READABLE MEDIUMFebruary 2023December 2025Abandon3401NoNo
18062663OPTICAL FIBER CONNECTOR AND ADAPTERDecember 2022August 2025Allow3210NoNo
18075859MULTI-CATHETER FLEXIBLE ROBOTIC SYSTEMDecember 2022April 2024Allow1620NoNo
18061357SYSTEMS AND METHODS FOR ENTERING AND EXITING A TELEOPERATIONAL STATEDecember 2022January 2024Allow1310NoNo
17985969METHOD FOR CONTROLLING FLOW IN A BODILY ORGANNovember 2022September 2023Allow1010NoNo
18050385TREATING EYE CONDITIONS WITH SUBTHRESHOLD FEMTOSECOND LASER PULSESOctober 2022February 2026Allow4011NoNo
17996814SYSTEM FOR LASER-BASED AMETROPIA CORRECTION, AND METHOD FOR THE ALIGNMENT THEREOFOctober 2022November 2025Allow3710NoNo
17965870STEERABLE INSTRUMENT COMPRISING A CILINDRICAL DIAMETER ADAPTATION SECTIONOctober 2022August 2024Allow2211YesNo
17965087LIGHT RADIATION DEVICE FOR MEDICAL TREATMENTOctober 2022November 2024Allow2520NoNo
17995560OPHTHALMIC SURGERY APPARATUSOctober 2022November 2025Abandon3810NoNo
17931255TUNABLE LIGHT SOURCESeptember 2022March 2024Allow1811YesNo
17903638TRANSCRANIAL STIMULATOR FOR REHABILITATION BASED ON PHOTOBIOMODULATION MECHANISMSeptember 2022December 2025Abandon3901NoNo
17823055MEDICAL DEVICE AND METHOD FOR DETECTING TACHYARRHYTHMIAAugust 2022September 2025Allow3711YesNo
17890829SURGICAL INSTRUMENT HOLDING DEVICE AND SURGERY ASSISTING DEVICEAugust 2022July 2025Allow3510NoNo
17886968METHOD FOR CONTROLLING A LASER OF A TREATMENT APPARATUS, TREATMENT APPARATUS, COMPUTER PROGRAM AS WELL AS COMPUTER-READABLE MEDIUMAugust 2022September 2025Abandon3711NoNo
17760396MASTER WORKSTATION FOR ROBOTIC SURGERY, STERILE OPERATORY FIELD, SURGICAL ROBOTIC SYSTEM AND METHODAugust 2022July 2025Allow3611YesNo
17815989LASER-INDUCED FLASHING ALERT, CONTROL, OR COMPENSATIONJuly 2022December 2025Allow4131YesNo
17857216ELECTROCARDIOGRAM DATA PROCESSING SERVER, METHOD OF CALCULATING EXPECTED ANALYSIS TIME REQUIRED FOR ELECTROCARDIOGRAM ANALYSIS, AND COMPUTER PROGRAM THEREFORJuly 2022August 2025Allow3821YesNo
17852261MECHANICALLY DECOUPLED CLOSURE SUBSYSTEMJune 2022May 2025Allow3521NoNo
17809100SYSTEMS AND METHODS FOR COMPUTATIONALLY EFFICIENT NON-INVASIVE BLOOD QUALITY MEASUREMENTJune 2022February 2025Allow3210NoNo
17788434SURGICAL ROBOTIC SYSTEMSJune 2022June 2025Allow3620NoNo
17840396STERILE DRAPE, SURGICAL ROBOT, AND METHOD OF ATTACHING STERILE DRAPEJune 2022March 2026Allow4531YesNo
17834059METHOD AND SYSTEM OF SENSING AND ANALYSIS FOR SKIN TREATMENT PROCEDURESJune 2022December 2025Abandon4221NoNo
17662829AUTOMATIC PATIENT POSITIONING WITHIN A LASER EYE SURGERY SYSTEMMay 2022March 2026Allow4611NoNo
17735901REPLACEABLE ARM GUIDE AND END EFFECTOR FOR SURGICAL SYSTEMSMay 2022October 2025Abandon4221NoNo
17771038PROGRAMMING DEVICE FOR PROGRAMMING AN IMPLANTABLE MEDICAL DEVICE FOR STIMULATING A HUMAN OR ANIMAL HEARTApril 2022May 2025Abandon3701NoNo
17767960APPARATUS AND METHOD FOR LENS SURGERYApril 2022March 2026Allow4722YesNo
17714756SYSTEMS AND METHODS OF TREATING MEDICAL INDICATIONS BY ADMINISTERING DOSAGES OF LIGHT AND SOUNDApril 2022October 2024Abandon3111NoNo
17689262SYSTEMS AND METHODS FOR AUTOMATED STRESS MONITORING AND INTERVENTIONMarch 2022April 2024Allow2520NoNo
17674195MACHINED FEATURES OF ENCLOSURES FOR IMPLANTABLE MEDICAL DEVICESFebruary 2022February 2024Allow2421NoNo
17631705STERILE INTERFACE MODULE FOR ROBOTIC SURGICAL ASSEMBLIESJanuary 2022April 2025Allow3820YesNo
17647660OCCLUSION SENSING IN OPHTHALMIC LASER PROBESJanuary 2022February 2024Allow2520NoNo
17565709METHOD AND SYSTEM FOR REAL TIME MONITORING OF COSMETIC LASER AESTHETIC SKIN TREATMENT PROCEDURESDecember 2021November 2025Abandon4621NoNo
17518175SURGICAL TOOL END EFFECTORS WITH ALIGNMENT ARMSNovember 2021December 2024Allow3821NoNo
17453065HYDROGEL CO-INJECTION AND REAL-TIME OPTO-ELECTROMAGNETIC MODIFICATION DEVICE FOR TUNABLE IN-VIVO DELIVERYNovember 2021May 2025Allow4321NoNo
17506613CONTROLLERS FOR ROBOTICALLY ENABLED TELEOPERATED SYSTEMSOctober 2021August 2023Allow2210NoNo
17500702QUICK CONNECT FOR ROBOTIC SURGERYOctober 2021September 2024Allow3511NoNo
17487692LIGHT THERAPY SYSTEMS AND METHODSSeptember 2021December 2023Allow2720NoNo
17598943Steerable instrument comprising a hinge with a slotted structureSeptember 2021June 2025Allow4420YesNo
17436706RHINITIS TREATMENT DEVICESeptember 2021July 2024Allow3420NoNo
17436747THERAPEUTIC IRRADIATION DEVICESeptember 2021February 2025Allow4230NoNo
17465674SYSTEM AND METHOD FOR DIAGNOSTIC ANALYSIS OF HUMAN BODY SYSTEMS, ORGANS, AND CELLSSeptember 2021August 2023Allow2420NoNo
17435100DEVICES, SYSTEMS, AND METHODS FOR MAINTAINING A STERILE SURGICAL FIELDAugust 2021February 2025Allow4211YesNo
17400888CONNECTOR ASSEMBLY FOR CONNECTING A ROBOTIC ARM WITH A SURGICAL END EFFECTORAugust 2021March 2026Abandon5541NoNo
17364246SURGICAL ROBOT SYSTEMS COMPRISING ROBOTIC TELEMANIPULATORS AND INTEGRATED LAPAROSCOPYJune 2021February 2025Allow4411YesNo
17364518DETERMINING MEDICAL STAFFING FOR ORAL IMMUNOTHERAPYJune 2021March 2025Allow4530YesNo
17350578DEVICE FOR ROBOT-ASSISTED SURGERYJune 2021September 2024Abandon3911NoNo
17312596COMPOSITIONS AND METHODS FOR TREATING WOUNDSJune 2021March 2024Abandon3310NoNo
17330642SET COMPRISING A SURGICAL INSTRUMENTMay 2021April 2024Allow3510YesNo
17323155DEVICES AND METHODS FOR APPLYING THERAPEUTIC LIGHT TO REDUCE HAZARD TO HEALTH CARE PROVIDERS OF CONTRACTING INFECTIOUS DISEASEMay 2021July 2024Allow3821NoNo
17244010Hydrotherapy Apparatus GlazingApril 2021November 2023Allow3020YesNo
17235650SMART PATCH FOR MONITORING HEALTH METRICSApril 2021November 2024Allow4330NoNo
17228292THERAPEUTIC LIGHTING DEVICES AND METHODSApril 2021August 2025Allow5251NoNo
17226235REAL TIME MONITORING OF COSMETIC LASER AESTHETIC SKIN TREATMENT PROCEDURESApril 2021April 2024Abandon3640NoYes
17205082SYSTEM AND METHOD FOR GENERATING GANZFELD EFFECTMarch 2021December 2023Abandon3320NoNo
17276511HIGHLY ARTICULATED LAPAROSCOPIC JOINT INCLUDING ELECTRICAL SIGNAL TRANSMISSION THERETHROUGHMarch 2021July 2024Allow4020NoNo
17201061DEVICES AND METHODS FOR ILLUMINATING TISSUE TO INDUCE BIOLOGICAL EFFECTSMarch 2021June 2024Allow3940NoNo
17275668TARGETED SEED IMPLANTING ROBOT SUITABLE FOR CLINICAL TREATMENT OF A HUMAN PATIENT IN THE LITHOTOMY POSITIONMarch 2021December 2023Allow3310NoNo
17273441SURGICAL ROBOTIC SYSTEMSMarch 2021January 2024Allow3510NoNo
17186652Device For Ablation Processing Of Ophthalmological Implantation MaterialFebruary 2021March 2025Abandon4861YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HOLTZCLAW, MICHAEL T..

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
1
(33.3%)
Examiner Reversed
2
(66.7%)
Reversal Percentile
88.1%
Higher than average

What This Means

With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
4
Allowed After Appeal Filing
1
(25.0%)
Not Allowed After Appeal Filing
3
(75.0%)
Filing Benefit Percentile
36.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner HOLTZCLAW, MICHAEL T. - Prosecution Strategy Guide

Executive Summary

Examiner HOLTZCLAW, MICHAEL T. works in Art Unit 3796 and has examined 58 patent applications in our dataset. With an allowance rate of 75.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 43 months.

Allowance Patterns

Examiner HOLTZCLAW, MICHAEL T.'s allowance rate of 75.9% places them in the 41% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by HOLTZCLAW, MICHAEL T. receive 2.64 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HOLTZCLAW, MICHAEL T. is 43 months. This places the examiner in the 17% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +10.8% benefit to allowance rate for applications examined by HOLTZCLAW, MICHAEL T.. This interview benefit is in the 45% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 30.4% of applications are subsequently allowed. This success rate is in the 60% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 33.3% of cases where such amendments are filed. This entry rate is in the 50% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 57.1% of appeals filed. This is in the 31% percentile among all examiners. Of these withdrawals, 25.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 100.0% are granted (fully or in part). This grant rate is in the 93% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 9.1% of allowed cases (in the 88% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.